Apolipoprotein B level and diabetic microvascular complications: is there a correlation?

• Published in: The Egyptian journal of internal medicine 2013-09, Vol.25 (3), p.137-142
• Main Authors: Rizk, Mary N., Aly, Hala, Samir, Pierre, Mofty, Hala el, Allah, Osama K.
• Format: Article
• Language: English
• Subjects: Apolipoproteins; Creatinine; Diabetes; Diabetic nephropathy; Internal Medicine; Lipoproteins; Medicine & Public Health; Metabolic disorders; Original Article
• ISSN: 1110-7782; 2090-9098
• DOI: 10.7123/01.EJIM.0000432236.92356.43

Introduction Dyslipidemia has long been implicated in diabetic complications. However, many subgroups have been considered to be responsible. Furthermore, a cause and effect relationship has long been debated. Apolipoprotein B (Apo B) is an exact measure of the total number of very low-density lipoprotein and low-density lipoprotein particles; thus, total plasma Apo B is a reliable surrogate for actual low-density lipoprotein particle number irrespective of its size. Hence, it is a better indicator of the correlation between dyslipidemia and diabetic microvascular complications. Aim of the work Our aim is to study the correlation between Apo B and diabetic microvascular complications, namely, nephropathy and retinopathy. Materials and methods A cross sectional study was carried out of 56 diabetic patients, 36 men and 20 women, both type 1 and 2, who were chosen randomly from the outpatient Endocrinology Clinic in Cairo University. Serum creatinine, estimated glomerular filtration rate, urine albumin/ creatinine ratio (A/C ratio), and Apo B levels were determined. Groups were divided according to the A/C ratio as follows: no proteinuria (A/C ratio300mg/g). We performed fundus examination as well as fluorescein angiography in patients with retinopathy. Patients on dialysis, HBA1c more than 7.5, on lipid-lowering treatment, or with familial hyperlipidemia were excluded. Calculations were carried out using the SPSS v.10 statistical software. Results We found a significant positive correlation between Apo B levels and microvascular complications. Apo B was higher with overt nephropathy than incipient nephropathy (1.75 ±0.38), and higher in patients with incipient nephropathy (1.4± 0.48) than in patients without nephropathy (1.02 ± 0.34, P